Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GOLFIG chemo-immunotherapy vs standard FOLFOX-4 in first-line metastatic colorectal cancer
2005-003458-81Phase 3Completed
- Sponsor
- Azienda Ospedaliera Universitaria Senese
- Start
- Feb 2007
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of gemcitabine, oxaliplatin, sargramostim and aldesleukin in colorectal cancer (CRC) (2 arms), sponsored by Azienda Ospedaliera Universitaria Senese. Started Feb 2007; status: completed.
02
Drugs
gemcitabineoxaliplatinsargramostimaldesleukin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2005-003458-81.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-003458-81.